SCHEMBL6168079

SCHEMBL6168079

CC1(c2ccc(Oc3ccccc3)cc2)NC(=S)N(c2ccc([N+](=O)[O-])cc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
KDM4E B2RXH2 2/20 0.42
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
PSD A5PKW4 1/20 0.41
SCN2A Q99250 1/20 0.40
CNR1 P21554 1/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
LPAR1 Q92633 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39
MGLL Q99685 1/20 0.39
MMP3 P08254 1/20 0.39
MMP8 P22894 1/20 0.39
MMP13 P45452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167711 0.89 CNR1 (0.50) LMNACNR1MMP2MMP9MGLL
SCHEMBL6168870 0.86 GAA (0.46) LMNAKDM4EMAPTMEN1KMT2A
SCHEMBL6169738 0.85 CNR1 (0.43) LMNAKDM4EMEN1KMT2ACNR1
SCHEMBL6168712 0.82 CNR1 (0.46) MAPTMEN1KMT2ACNR1MMP2
SCHEMBL6625449 0.78 MAPT (0.47) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL6168455 0.78 PGR (0.41) LMNAMEN1KMT2ACNR1MMP2
SCHEMBL6167462 0.78 CNR1 (0.41) LMNACNR1MMP2MMP9MGLL
SCHEMBL6170632 0.77 ALDH1A1 (0.46) MAPTMMP13ALDH1A1SMN1; SMN2
SCHEMBL7481341 0.77 CNR1 (0.55) LMNAKDM4EMAPTMEN1KMT2A
SCHEMBL6170930 0.76 HSD11B1 (0.44) LMNAKDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed